Lawmaker Questions FDAs Secretive Fast-Track Drug Program
#FDA #DrugSafetyA Democratic lawmaker raises concerns over an FDA program that expedites drug reviews, citing secrecy and potential ethics violations. He questions its legality and transparency, as agency staff debate the shift of decision-making from scientists. read more
There are no other DrugSafety articles to read at this time.
Check out some of these other topics...